{"id":1512,"date":"2002-05-01T12:05:00","date_gmt":"2002-05-01T10:05:00","guid":{"rendered":"https:\/\/der-arzneimittelbrief.com\/artikel\/2002\/leserbrief-ornipressin-in-lokalanaesthetika"},"modified":"2002-05-01T12:05:00","modified_gmt":"2002-05-01T10:05:00","slug":"leserbrief-ornipressin-in-lokalanaesthetika","status":"publish","type":"post","link":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/leserbrief-ornipressin-in-lokalanaesthetika\/","title":{"rendered":"Leserbrief: Ornipressin in Lokalan\u00e4sthetika"},"content":{"rendered":"<p>Frage von Dr. W.K. aus Sinsheim: >> Gibt es ein \u00c4quivalenzpr\u00e4parat f\u00fcr Ornipressin, das &#8211; abgesehen von Katecholaminen &#8211; als Additivum zur Lokalan\u00e4sthesie geeignet ist? Durch Verz\u00f6gerung der lokalen Resorption k\u00f6nnen Vasopressoren die Wirkdauer von Lokalan\u00e4sthetika verl\u00e4ngern und die Toxizit\u00e4t reduzieren. Ornipressin bzw. POR 8 ist ein synthetisches Vasopressin, das h\u00e4ufig als Vasopressorzusatz f\u00fcr Lokalan\u00e4sthetika [&hellip;]<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Frage von Dr. W.K. aus Sinsheim: >> Gibt es ein \u00c4quivalenzpr\u00e4parat f\u00fcr Ornipressin, das &#8211; abgesehen von Katecholaminen &#8211; als Additivum zur Lokalan\u00e4sthesie geeignet ist? Durch Verz\u00f6gerung der lokalen Resorption k\u00f6nnen Vasopressoren die Wirkdauer von Lokalan\u00e4sthetika verl\u00e4ngern und die Toxizit\u00e4t reduzieren. Ornipressin bzw. POR 8 ist ein synthetisches Vasopressin, das h\u00e4ufig als Vasopressorzusatz f\u00fcr Lokalan\u00e4sthetika [&hellip;]<\/p>\n","protected":false},"author":6,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_editorskit_title_hidden":false,"_editorskit_reading_time":0,"_editorskit_is_block_options_detached":false,"_editorskit_block_options_position":"{}","footnotes":""},"categories":[1],"tags":[1233,1235,4961,5656,6078,6218,6280],"class_list":["post-1512","post","type-post","status-publish","format-standard","hentry","category-allgemein","tag-adrenalin","tag-epinephrin","tag-felypressin","tag-lokalanaesthetika","tag-ornipressin","tag-phenylephrin","tag-por-8"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Leserbrief: Ornipressin in Lokalan\u00e4sthetika - Der Arzneimittelbrief<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/leserbrief-ornipressin-in-lokalanaesthetika\/\" \/>\n<meta property=\"og:locale\" content=\"de_DE\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Leserbrief: Ornipressin in Lokalan\u00e4sthetika - Der Arzneimittelbrief\" \/>\n<meta property=\"og:description\" content=\"Frage von Dr. W.K. aus Sinsheim: &gt;&gt; Gibt es ein \u00c4quivalenzpr\u00e4parat f\u00fcr Ornipressin, das &#8211; abgesehen von Katecholaminen &#8211; als Additivum zur Lokalan\u00e4sthesie geeignet ist? Durch Verz\u00f6gerung der lokalen Resorption k\u00f6nnen Vasopressoren die Wirkdauer von Lokalan\u00e4sthetika verl\u00e4ngern und die Toxizit\u00e4t reduzieren. Ornipressin bzw. POR 8 ist ein synthetisches Vasopressin, das h\u00e4ufig als Vasopressorzusatz f\u00fcr Lokalan\u00e4sthetika [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/leserbrief-ornipressin-in-lokalanaesthetika\/\" \/>\n<meta property=\"og:site_name\" content=\"Der Arzneimittelbrief\" \/>\n<meta property=\"article:publisher\" content=\"http:\/\/www.facebook.com\/derarzneimittelbrief.de\" \/>\n<meta property=\"article:published_time\" content=\"2002-05-01T10:05:00+00:00\" \/>\n<meta property=\"og:image\" content=\"http:\/\/www.der-arzneimittelbrief.de\/nachrichten\/wp-content\/uploads\/2012\/06\/logo_amb_neu.jpg\" \/>\n<meta name=\"author\" content=\"Dennis Hoppe\" \/>\n<meta name=\"twitter:label1\" content=\"Verfasst von\" \/>\n\t<meta name=\"twitter:data1\" content=\"Dennis Hoppe\" \/>\n\t<meta name=\"twitter:label2\" content=\"Gesch\u00e4tzte Lesezeit\" \/>\n\t<meta name=\"twitter:data2\" content=\"1\u00a0Minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.der-arzneimittelbrief.de\\\/nachrichten\\\/leserbrief-ornipressin-in-lokalanaesthetika\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.der-arzneimittelbrief.de\\\/nachrichten\\\/leserbrief-ornipressin-in-lokalanaesthetika\\\/\"},\"author\":{\"name\":\"Dennis Hoppe\",\"@id\":\"https:\\\/\\\/www.der-arzneimittelbrief.de\\\/nachrichten\\\/#\\\/schema\\\/person\\\/a04aadd6db7c06c7464bdbbb5396ed16\"},\"headline\":\"Leserbrief: Ornipressin in Lokalan\u00e4sthetika\",\"datePublished\":\"2002-05-01T10:05:00+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.der-arzneimittelbrief.de\\\/nachrichten\\\/leserbrief-ornipressin-in-lokalanaesthetika\\\/\"},\"wordCount\":245,\"keywords\":[\"Adrenalin\",\"Epinephrin\",\"Felypressin\",\"Lokalan\u00e4sthetika\",\"Ornipressin\",\"Phenylephrin\",\"POR 8\"],\"inLanguage\":\"de\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.der-arzneimittelbrief.de\\\/nachrichten\\\/leserbrief-ornipressin-in-lokalanaesthetika\\\/\",\"url\":\"https:\\\/\\\/www.der-arzneimittelbrief.de\\\/nachrichten\\\/leserbrief-ornipressin-in-lokalanaesthetika\\\/\",\"name\":\"Leserbrief: Ornipressin in Lokalan\u00e4sthetika - Der Arzneimittelbrief\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.der-arzneimittelbrief.de\\\/nachrichten\\\/#website\"},\"datePublished\":\"2002-05-01T10:05:00+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.der-arzneimittelbrief.de\\\/nachrichten\\\/#\\\/schema\\\/person\\\/a04aadd6db7c06c7464bdbbb5396ed16\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.der-arzneimittelbrief.de\\\/nachrichten\\\/leserbrief-ornipressin-in-lokalanaesthetika\\\/#breadcrumb\"},\"inLanguage\":\"de\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.der-arzneimittelbrief.de\\\/nachrichten\\\/leserbrief-ornipressin-in-lokalanaesthetika\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.der-arzneimittelbrief.de\\\/nachrichten\\\/leserbrief-ornipressin-in-lokalanaesthetika\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Start\",\"item\":\"https:\\\/\\\/www.der-arzneimittelbrief.de\\\/nachrichten\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Leserbrief: Ornipressin in Lokalan\u00e4sthetika\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.der-arzneimittelbrief.de\\\/nachrichten\\\/#website\",\"url\":\"https:\\\/\\\/www.der-arzneimittelbrief.de\\\/nachrichten\\\/\",\"name\":\"Der Arzneimittelbrief\",\"description\":\"Unabh\u00e4ngige Arzneimittelinformationen\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.der-arzneimittelbrief.de\\\/nachrichten\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"de\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.der-arzneimittelbrief.de\\\/nachrichten\\\/#\\\/schema\\\/person\\\/a04aadd6db7c06c7464bdbbb5396ed16\",\"name\":\"Dennis Hoppe\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"de\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/bfb16656c0e1636d4f543ef457ada76f291324632a293160dd5c869cc3b071d7?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/bfb16656c0e1636d4f543ef457ada76f291324632a293160dd5c869cc3b071d7?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/bfb16656c0e1636d4f543ef457ada76f291324632a293160dd5c869cc3b071d7?s=96&d=mm&r=g\",\"caption\":\"Dennis Hoppe\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Leserbrief: Ornipressin in Lokalan\u00e4sthetika - Der Arzneimittelbrief","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/leserbrief-ornipressin-in-lokalanaesthetika\/","og_locale":"de_DE","og_type":"article","og_title":"Leserbrief: Ornipressin in Lokalan\u00e4sthetika - Der Arzneimittelbrief","og_description":"Frage von Dr. W.K. aus Sinsheim: >> Gibt es ein \u00c4quivalenzpr\u00e4parat f\u00fcr Ornipressin, das &#8211; abgesehen von Katecholaminen &#8211; als Additivum zur Lokalan\u00e4sthesie geeignet ist? Durch Verz\u00f6gerung der lokalen Resorption k\u00f6nnen Vasopressoren die Wirkdauer von Lokalan\u00e4sthetika verl\u00e4ngern und die Toxizit\u00e4t reduzieren. Ornipressin bzw. POR 8 ist ein synthetisches Vasopressin, das h\u00e4ufig als Vasopressorzusatz f\u00fcr Lokalan\u00e4sthetika [&hellip;]","og_url":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/leserbrief-ornipressin-in-lokalanaesthetika\/","og_site_name":"Der Arzneimittelbrief","article_publisher":"http:\/\/www.facebook.com\/derarzneimittelbrief.de","article_published_time":"2002-05-01T10:05:00+00:00","og_image":[{"url":"http:\/\/www.der-arzneimittelbrief.de\/nachrichten\/wp-content\/uploads\/2012\/06\/logo_amb_neu.jpg","type":"","width":"","height":""}],"author":"Dennis Hoppe","twitter_misc":{"Verfasst von":"Dennis Hoppe","Gesch\u00e4tzte Lesezeit":"1\u00a0Minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/leserbrief-ornipressin-in-lokalanaesthetika\/#article","isPartOf":{"@id":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/leserbrief-ornipressin-in-lokalanaesthetika\/"},"author":{"name":"Dennis Hoppe","@id":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/#\/schema\/person\/a04aadd6db7c06c7464bdbbb5396ed16"},"headline":"Leserbrief: Ornipressin in Lokalan\u00e4sthetika","datePublished":"2002-05-01T10:05:00+00:00","mainEntityOfPage":{"@id":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/leserbrief-ornipressin-in-lokalanaesthetika\/"},"wordCount":245,"keywords":["Adrenalin","Epinephrin","Felypressin","Lokalan\u00e4sthetika","Ornipressin","Phenylephrin","POR 8"],"inLanguage":"de"},{"@type":"WebPage","@id":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/leserbrief-ornipressin-in-lokalanaesthetika\/","url":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/leserbrief-ornipressin-in-lokalanaesthetika\/","name":"Leserbrief: Ornipressin in Lokalan\u00e4sthetika - Der Arzneimittelbrief","isPartOf":{"@id":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/#website"},"datePublished":"2002-05-01T10:05:00+00:00","author":{"@id":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/#\/schema\/person\/a04aadd6db7c06c7464bdbbb5396ed16"},"breadcrumb":{"@id":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/leserbrief-ornipressin-in-lokalanaesthetika\/#breadcrumb"},"inLanguage":"de","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/leserbrief-ornipressin-in-lokalanaesthetika\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/leserbrief-ornipressin-in-lokalanaesthetika\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Start","item":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/"},{"@type":"ListItem","position":2,"name":"Leserbrief: Ornipressin in Lokalan\u00e4sthetika"}]},{"@type":"WebSite","@id":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/#website","url":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/","name":"Der Arzneimittelbrief","description":"Unabh\u00e4ngige Arzneimittelinformationen","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"de"},{"@type":"Person","@id":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/#\/schema\/person\/a04aadd6db7c06c7464bdbbb5396ed16","name":"Dennis Hoppe","image":{"@type":"ImageObject","inLanguage":"de","@id":"https:\/\/secure.gravatar.com\/avatar\/bfb16656c0e1636d4f543ef457ada76f291324632a293160dd5c869cc3b071d7?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/bfb16656c0e1636d4f543ef457ada76f291324632a293160dd5c869cc3b071d7?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/bfb16656c0e1636d4f543ef457ada76f291324632a293160dd5c869cc3b071d7?s=96&d=mm&r=g","caption":"Dennis Hoppe"}}]}},"_links":{"self":[{"href":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/api\/wp\/v2\/posts\/1512","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/api\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/api\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/api\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/api\/wp\/v2\/comments?post=1512"}],"version-history":[{"count":0,"href":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/api\/wp\/v2\/posts\/1512\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/api\/wp\/v2\/media?parent=1512"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/api\/wp\/v2\/categories?post=1512"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/api\/wp\/v2\/tags?post=1512"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}